期刊文献+

胱抑素C在心脑血管疾病方面的研究进展 被引量:1

原文传递
导出
摘要 胱抑素C(Cys-C)是一种表达于人体内几乎所有有核细胞中的蛋白质,参与细胞内外蛋白水解的调控,属于半胱氨酸蛋白酶抑制剂超家族的成员[1]。因集恒定的血液生成速率、可自由滤过肾小球、肾小管不分泌并可完全被肾小管重吸收等特点于一身,使其成为了一种反映肾小球滤过功能细微变化的理想标志物[2]。但近年不少研究显示,Cys-C与心脑血管疾病事件密切相关,参与了心脑血管疾病的发生与发展。
出处 《中国卫生检验杂志》 CAS 2015年第22期3982-3984,共3页 Chinese Journal of Health Laboratory Technology
  • 相关文献

参考文献26

  • 1Page MK, Bukki J, Luppa P, et al. Clinical value of cystatin C de- termination[ J]. Clin Chim Acta, 2000, 297 (2) : 67 -72.
  • 2潘顺文,代群,廖媛,周莉,凌小强.血清CysC联合β_2-MG检测在诊断肾脏疾病中的应用[J].中国卫生检验杂志,2014,24(21):3108-3110. 被引量:12
  • 3Angelidis C, Deftereos S, Giannopoulos G, et al. Cystatin C : an e- merging biomarker in cardiovascular disease [ J ]. N Engl J Med, 2013, 13(2): 164-179.
  • 4Fenster BE, Lasalvia L, Schroedar JD, et al. Cystatin C : a poten- tial biomarker for pulmonary arterial hypertension[J]. Respirology, 2014, 19(4) : 583 -589.
  • 5Lofberg H, Grubb AO. Quantitation of gamma - trace in human bi- ological fluids: indications for production in the central nervous sys- tem[J]. Stand J Clin Lab Invest, 1979, 39(2) : 619 -626.
  • 6Hossain MA, Emma M, Moselhi H, et al. Comparing measures of cystatin C in human sera by three methods [ J ]. Am J Nephrol, 2009, 29 (3) : 381 -391.
  • 7Ristiniemi N, Qin QP, Lindstrom V, et al. Quantification of cysta- tin C by time - resolved fluorometry - based immunoassays [ J ]. J Immunol Methods, 2012, 378(1/2) : 56 -61.
  • 8Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in hu- man atheroselerosis and aortic aneurysms[ J]. J Clin Invest, 1999, 104(9) : 1191 -1197.
  • 9Lindholt JS, Erlandsen E J, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneu- rysms[J]. Br J Surg, 2001,88(11) : 1472 -1475.
  • 10Schulte S, Sun J, Libby P, et al. Cystatin C deficiency promotes in- flammation in angiotensin II - induced abdominal aortic aneurisms in atherosclerotic mice[ J ]. Am J Pathol, 2010, 177 (1) : 456 -463.

二级参考文献20

  • 1卢芝君.重度子痫前期患者血清胱抑素C与尿酸测定的临床意义[J].江西医学检验,2007,25(2):133-134. 被引量:8
  • 2SABOURET P, CACOUB P, DALLONGEVILLE J,et al. REACH: international prospective observation- al registry in patients at risk of atherothromhotic e- vents. Results for the French arm at baseline and one year[J]. Arch Cardiovasc Dis, 2008,101 : 81 - 88.
  • 3NEWMAN D J, THAKKAR H, EDWARDS R G, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum ereatinine[J].Kidney Int, 1995,47 : 312- 318.
  • 4ARPEGARD J, OSTERGREN J, DE FAIRE U. Cystatin C a marker of peripheral atherosclerotic disease[J]. Atheroselerosis,2008,199 : 397- 401.
  • 5NURKIC J, LJUCA F, NURKIC M, et al. Biomark- ers of plaque instability in acute coronary syndrome patients[J]. Med Arh. 2010, 64:103-106.
  • 6DE NOOIJER R, VERKLEIJ C J, VON DER THfQSEN J H, et al. Lesional overexpression of ma- trix metalloproteinase-9 promotes intraplaque hemor- rhage in advanced lesions but not at earlier stages of atherogenesi[J]. Arterioscler Thromb Vase Biol, 2006,26:340-346.
  • 7NEWBY A C, GEORGE S J, ISMAIL Y, et al. Vul- nerable atherosclerotic plaque metalloproteinases and foam cell phenotypes[J]. Thromb Haemost, 2009, 101 : 1006- 1011.
  • 8NOTO D, CEFALU A B, BARBAGALLO C M, et al. Cystatin C levels are decreased in acute myocardial infarction: effect of cystatin C G73A gene polymor- phism on plasma levels[J]. Int J Cardiol, 2005,101 : 213-217.
  • 9SCHULTE S, SUN J, LIBBY P, et al. Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice[J].Am J Pathol,2010,177:456-463.
  • 10SAEMANN M D, POGLITSCH M, KOPECKY C, et al. The versatility of HDL : a crucial anti-inflamma- tory regulator[J]. Eur J Clin Invest, 2010,40 : 1131 - 1143.

共引文献49

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部